Pete Sampras Vs. Roger Federer; The NetJets Showdown: A Battle for Tennis History
Dream Vaccines Foundation and Mymetics Corporation (OTCBB: MYMX), in association with the Marquis Jet Card and Men’s Vogue, are proud to present the “NetJets Showdown: a Battle for Tennis History.” This is the first fundraising event for the newly launched Dream Vaccines Foundation, a not-for-profit organization* that aspires to be the avenue through which vaccines can be tested and delivered to underserved and impoverished populations.
The event, a StarGames production in conjunction with 8-time Grand Slam champion Ivan Lendl, features tennis legend Pete Sampras, emerging from retirement, and Roger Federer, the world’s number one ranked player since 2004, in an historic tennis match on Monday, March 10, 2008 at New York City’s Madison Square Garden, the World’s Most Famous Arena.
Pre-match entertainment and opening festivities will begin at 6:00PM with the match slated to begin at 8:30PM EDT. The event will be broadcast nationally on the Tennis Channel and locally on MSG Plus with worldwide television and broadband distribution on the www.tvunetworks.com.
Event goers will have the opportunity to participate in a silent auction held on location at two MSG sites, with autographed tennis memorabilia among the items being auctioned.
“We believe that access to vaccines is a basic human right that belongs to all, irrespective of location or market limitations,” says Christian J. F. Rochet, director and fundraising chairman of Dream Vaccines Foundation, and CEO and president of Mymetics Corporation. “We are delighted to be joined by luminaries from the worlds of sport, entertainment, business and science, to bring attention to worldwide malaria prevention and Dream Vaccines Foundation’s initiative for a vaccine that can help eradicate this terrible disease.”
ABOUT DREAM VACCINES FOUNDATION
“Access To Vaccines Is A Basic Human Right”
Dream Vaccines Foundation is a not-for-profit, American-based public foundation that aspires to be an avenue through which vaccines can be tested and delivered to underserved and poor populations. Dream Vaccines Foundation was established by Mymetics Corporation (OTCBB: MYMX), a biotechnology company developing prophylactic vaccines that combine innovative antigen engineering, minimal human protein homologies and virosome© technology in the battle against the human immunodeficiency virus and acquired immune deficiency syndrome (“HIV/AIDS”), malaria and similar retroviruses. Mymetics believes it is possible to create shareholder value while fostering a more transparent and straightforward avenue for vaccines to reach underserved and impoverished populations that are suitable without compromising profitability; yet, at an affordable price point.
The Foundation is keenly aware of the significant impact new vaccines may have on improving public health and generating economic benefits for underserved and poor populations; especially in third world countries that have been devastated by HIV/AIDS and malaria. The Foundation assumes an ethical responsibility to those suffering from these diseases regardless of strain, location, market limitations or ability to pay.
It is the Foundation’s vision to make vaccines available to all populations threatened by these life-threatening diseases in a world where approximately:
33.2 million people live with HIV
2.5 million people become newly infected with HIV each year
2.1 million lose their lives to AIDS each year
Three hundred million to five hundred million people suffer from malaria, resulting in an estimated one to 2.7 million deaths each year
For more information about the Foundation, please visit http://www.dreamvaccinesfoundation.org.
About Mymetics Corporation
Mymetics is a biotechnology company developing prophylactic vaccines that combine innovative antigen engineering, minimal human protein homologies and virosome© technology. Mymetics’ vaccine approach is focused on eliciting immune protection capable of interfering with late events of pathogen transmission, coupled, most importantly, with early events of pathogen transmission, such as preventing the entry across the mucosal tissues that are very often the primary entry door of most of the pathogens. Virosomes© are biosynthetic vesicles representing reconstituted empty influenza virus envelopes that serve as a highly efficient vaccine delivery system with intrinsic adjuvant potential. The Company’s disease focus presently includes malaria and the human immunodeficiency virus.
For further information regarding the Company and its mucosal approach, please visit www.mymetics.com.
About MSG Sports Properties
MSG Sports Properties is part of Madison Square Garden, L.P., owned by Cablevision Systems Corporation, and includes the New York Knicks (NBA); the New York Rangers (NHL); the New York Liberty (WNBA); the Hartford Wolf Pack (American Hockey League); MSG Entertainment, which includes concerts and events at Radio City Music Hall, Madison Square Garden, The WaMu Theater at Madison Square Garden, and the Beacon Theatre; MSG Media, which is comprised of MSG and FSN New York; fuse, the music television network; and the Madison Square Garden arena complex, located in the heart of the New York metropolitan area.
About StarGames, LLC
StarGames, LLC (www.stargamesinc.com) is a full service sports marketing and production company based outside of Boston, MA. Now in its 14th year, StarGames produces programming for television, broadband and DVD home distribution. In addition, StarGames creates and produces live sporting/entertainment events, represents professional athletes and operates its own broadband channels through affiliations with YouTube and TVUNetworks.
About NetJets Inc.
NetJets Inc., a Berkshire Hathaway company, is the worldwide leader in private aviation and provides the safest and most secure private aviation solutions. NetJets fractional aircraft ownership allows individuals and companies to buy a share of a private business jet at a fraction of the cost of whole aircraft ownership, and guarantees availability 365 days a year with just a few hours’ notice. The NetJets programs worldwide offer the largest and most diversified fleet in private aviation, which includes 15 of the most popular business jets in the world. Access to the NetJets fleet is also available in the form of a short-term lease, sold on an all-inclusive, pre-paid basis in 25-hour increments, through an exclusive alliance with Marquis Jet Partners. NetJets Inc. also offers aircraft management, charter management, and on-demand charter services through its subsidiary, Executive Jet Management. More information on NetJets, the Marquis Jet Program, and Executive Jet Management is available at www.netjets.com.
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are “forward-looking statements.” Such forward-looking statements are sometimes identified by words such as “intends,”"anticipates,”"believes,”"expects,” and “hopes.” The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
* IRS application pending